Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03954210 · ClinicalTrials.gov registry record · NA
SIESTA: Sleep Intervention to Enhance Cognitive Status and Reduce Beta Amyloid
A NA study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT03954210 is a NA study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 200 participants.
The verdict
NCT03954210, a NA study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The objective of this study is to compare the efficacy of a sleep intervention on improving cognitive function in older adults with symptoms of insomnia, determine the association between change in sleep measures and change in cognitive function, and examine the efficacy of the sleep intervention on reducing the rate of Aβ deposition. Participants, ages 60-85, will be randomly assigned to a six-week sleep intervention program. A sub-group of fifty participants will undergo Florbetapir-Positron-emission tomography (PET) imaging during the one-year reassessment to examine the efficacy of the sleep intervention on reducing the rate of Aβ accumulation from baseline to one-year post-intervention.
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy for Insomnia (CBT-I)
- BEHAVIORAL Sleep and Lifestyle Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2019-08-27 |
| Est. Completion | 2025-04-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03954210
The ClinicalTrials.gov registry entry for NCT03954210 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first listed.
NCT03954210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03954210 about?
NCT03954210 is a clinical study titled "SIESTA: Sleep Intervention to Enhance Cognitive Status and Reduce Beta Amyloid". The objective of this study is to compare the efficacy of a sleep intervention on improving cognitive function in older adults with symptoms of insomnia, determine the association between change in sleep measures and change in cognitive function, and examine the efficacy of the sleep intervention on...
What is the current status of trial NCT03954210?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2019-08-27. Estimated completion is 2025-04-18.
What interventions are being tested in trial NCT03954210?
The interventions under investigation include: Cognitive Behavioral Therapy for Insomnia (CBT-I) (BEHAVIORAL), Sleep and Lifestyle Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT03954210?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.